Your browser doesn't support javascript.
loading
A "spindle and thread" mechanism unblocks p53 translation by modulating N-terminal disorder.
Kaldmäe, Margit; Vosselman, Thibault; Zhong, Xueying; Lama, Dilraj; Chen, Gefei; Saluri, Mihkel; Kronqvist, Nina; Siau, Jia Wei; Ng, Aik Seng; Ghadessy, Farid J; Sabatier, Pierre; Vojtesek, Borivoj; Sarr, Médoune; Sahin, Cagla; Österlund, Nicklas; Ilag, Leopold L; Väänänen, Venla A; Sedimbi, Saikiran; Arsenian-Henriksson, Marie; Zubarev, Roman A; Nilsson, Lennart; Koeck, Philip J B; Rising, Anna; Abelein, Axel; Fritz, Nicolas; Johansson, Jan; Lane, David P; Landreh, Michael.
Afiliación
  • Kaldmäe M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet - Biomedicum, Solnavägen 9, 17165 Solna, Sweden. Electronic address: Margit.Kaldmae@ki.se.
  • Vosselman T; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet - Biomedicum, Solnavägen 9, 17165 Solna, Sweden.
  • Zhong X; Department of Biomedical Engineering and Health Systems, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), KTH Royal Institute of Technology, 141 83 Huddinge, Sweden.
  • Lama D; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet - Biomedicum, Solnavägen 9, 17165 Solna, Sweden.
  • Chen G; Department of Biosciences and Nutrition, Karolinska Institutet, 148 13 Huddinge, Sweden.
  • Saluri M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet - Biomedicum, Solnavägen 9, 17165 Solna, Sweden; School of Natural Sciences and Health, Tallinn University, Narva mnt 25, 10120 Tallinn, Estonia.
  • Kronqvist N; Department of Biosciences and Nutrition, Karolinska Institutet, 148 13 Huddinge, Sweden.
  • Siau JW; Disease Intervention Technology Laboratory, Institute of Molecular and Cell Biology, A(∗)STAR, 8A Biomedical Grove #06-06 Immunos, Singapore 138648, Singapore.
  • Ng AS; Disease Intervention Technology Laboratory, Institute of Molecular and Cell Biology, A(∗)STAR, 8A Biomedical Grove #06-06 Immunos, Singapore 138648, Singapore.
  • Ghadessy FJ; Disease Intervention Technology Laboratory, Institute of Molecular and Cell Biology, A(∗)STAR, 8A Biomedical Grove #06-06 Immunos, Singapore 138648, Singapore.
  • Sabatier P; Division of Physiological Chemistry I, Department of Medical Biochemistry and 5 Biophysics, Karolinska Institutet - Biomedicum, Solnavägen 9, 17165 Solna, Sweden.
  • Vojtesek B; Masaryk Memorial Cancer Institute, RECAMO, Zluty kopec 7, 656 53 Brno, Czech Republic.
  • Sarr M; Department of Biosciences and Nutrition, Karolinska Institutet, 148 13 Huddinge, Sweden.
  • Sahin C; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet - Biomedicum, Solnavägen 9, 17165 Solna, Sweden.
  • Österlund N; Department of Biochemistry and Biophysics, Stockholm University, 10691 Stockholm, Sweden.
  • Ilag LL; Department of Materials and Environmental Chemistry, Stockholm University, 10691 Stockholm, Sweden.
  • Väänänen VA; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet - Biomedicum, Solnavägen 9, 17165 Solna, Sweden.
  • Sedimbi S; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet - Biomedicum, Solnavägen 9, 17165 Solna, Sweden.
  • Arsenian-Henriksson M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet - Biomedicum, Solnavägen 9, 17165 Solna, Sweden.
  • Zubarev RA; Division of Physiological Chemistry I, Department of Medical Biochemistry and 5 Biophysics, Karolinska Institutet - Biomedicum, Solnavägen 9, 17165 Solna, Sweden; Department of Pharmacological & Technological Chemistry, I.M. Sechenov First Moscow State Medical University, Moscow, 119146, Russia;
  • Nilsson L; Department of Biosciences and Nutrition, Karolinska Institutet, 148 13 Huddinge, Sweden.
  • Koeck PJB; Department of Biomedical Engineering and Health Systems, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), KTH Royal Institute of Technology, 141 83 Huddinge, Sweden; Department of Biosciences and Nutrition, Karolinska Institutet, 148 13 Huddinge, Sweden.
  • Rising A; Department of Biosciences and Nutrition, Karolinska Institutet, 148 13 Huddinge, Sweden; Department of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, Box 7011, Uppsala 750 07, Sweden.
  • Abelein A; Department of Biosciences and Nutrition, Karolinska Institutet, 148 13 Huddinge, Sweden.
  • Fritz N; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet - Biomedicum, Solnavägen 9, 17165 Solna, Sweden.
  • Johansson J; Department of Biosciences and Nutrition, Karolinska Institutet, 148 13 Huddinge, Sweden. Electronic address: Janne.Johansson@ki.se.
  • Lane DP; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet - Biomedicum, Solnavägen 9, 17165 Solna, Sweden.
  • Landreh M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet - Biomedicum, Solnavägen 9, 17165 Solna, Sweden. Electronic address: Michael.Landreh@ki.se.
Structure ; 30(5): 733-742.e7, 2022 05 05.
Article en En | MEDLINE | ID: mdl-35290795
ABSTRACT
Disordered proteins pose a major challenge to structural biology. A prominent example is the tumor suppressor p53, whose low expression levels and poor conformational stability hamper the development of cancer therapeutics. All these characteristics make it a prime example of "life on the edge of solubility." Here, we investigate whether these features can be modulated by fusing the protein to a highly soluble spider silk domain (NT∗). The chimeric protein displays highly efficient translation and is fully active in human cancer cells. Biophysical characterization reveals a compact conformation, with the disordered transactivation domain of p53 wrapped around the NT∗ domain. We conclude that interactions with NT∗ help to unblock translation of the proline-rich disordered region of p53. Expression of partially disordered cancer targets is similarly enhanced by NT∗. In summary, we demonstrate that inducing co-translational folding via a molecular "spindle and thread" mechanism unblocks protein translation in vitro.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Neoplasias Límite: Humans Idioma: En Revista: Structure Asunto de la revista: BIOLOGIA MOLECULAR / BIOQUIMICA / BIOTECNOLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Neoplasias Límite: Humans Idioma: En Revista: Structure Asunto de la revista: BIOLOGIA MOLECULAR / BIOQUIMICA / BIOTECNOLOGIA Año: 2022 Tipo del documento: Article